← Browse by Condition
Medical Condition

hypertension

Total Trials
55
Recruiting Now
55
Trial Phases
Phase 1, Phase 2, EARLY_Phase 1

Hypertension remains the most common treatable cardiovascular risk factor globally, yet blood pressure control rates remain suboptimal despite multiple effective drug classes. Clinical trials now investigate novel mechanisms including aldosterone synthase inhibitors, renal denervation devices, and RNA-based therapies targeting angiotensinogen to achieve durable pressure reduction with minimal pill burden.

Active research includes zilebesiran (RNA interference targeting angiotensinogen), baxdrostat (aldosterone synthase inhibitor), ultrasound renal denervation (Symplicity HTN-4), and resistant hypertension approaches combining SGLT2 inhibitors with MRA spironolactone. Ambulatory blood pressure monitoring is increasingly used as the primary endpoint instead of clinic readings.

Frequently Asked Questions — hypertension Clinical Trials

How many clinical trials are currently recruiting for hypertension?
ClinicalMetric currently tracks 55 actively recruiting clinical trials for hypertension, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 55. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hypertension?
hypertension research spans Phase 1 (4 trials), Phase 2 (2 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hypertension clinical trial?
Eligibility criteria for hypertension trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
4
Phase 2
2
Phase 4
2
Top Sponsors
Wake Forest University Health Sciences 2 trials
Aktiia SA 2 trials
University of Texas Southwestern Medical Center 2 trials
National Heart Centre Singapore 1 trial
Duke University 1 trial

Recruiting Clinical Trials

NCT02670031
Recruiting
Response of the Myocardium to Hypertrophic Conditions in the Adult Population
Enrollment
2,000 pts
Location
Singapore
Sponsor
National Heart Centre Singapor...
View Trial →
NCT06596265
Recruiting
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
Enrollment
1,000 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT05369065 Phase 1
Recruiting
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Enrollment
60 pts
Location
Georgia
Sponsor
Neurotronic, Inc.
View Trial →
NCT04752293
Recruiting
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Enrollment
125 pts
Location
United States
Sponsor
Wake Forest University Health ...
View Trial →
NCT07413159
Recruiting
The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
Enrollment
480 pts
Location
United States
Sponsor
Texas Southern University
View Trial →
NCT02880631
Recruiting
BAROSTIM THERAPY™ In Resistant Hypertension
Enrollment
500 pts
Location
Germany, Netherlands
Sponsor
CVRx, Inc.
View Trial →
NCT06558877
Recruiting
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
Enrollment
1,200 pts
Location
China
Sponsor
Xijing Hospital
View Trial →
NCT06822439
Recruiting
Remote Fetal Monitoring in High Risk Pregnancies
Enrollment
50 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT07115953
Recruiting
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Enrollment
130 pts
Location
Australia, Belgium, ...
Sponsor
Medtronic Vascular
View Trial →
NCT07730879
Recruiting
How Wall Squat Exercise Affects Blood Pressure in People With High Blood Pressure and Treated Sleep Apnea (WALLPRESS)
Enrollment
20 pts
Location
Portugal
Sponsor
Aveiro University
View Trial →
NCT07238556
Recruiting
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Enrollment
72 pts
Location
United States
Sponsor
University of Connecticut
View Trial →
NCT06368206
Recruiting
Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with Double Auscultatory and Pulse Oximetry to Evaluate the Effectiveness of an Optical Blood Pressure Monitoring (OBPM)
Enrollment
85 pts
Location
Switzerland
Sponsor
Aktiia SA
View Trial →
NCT05979168
Recruiting
Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal
Enrollment
500 pts
Location
Nepal
Sponsor
Central Department of Public H...
View Trial →
NCT02132741
Recruiting
Optical Coherence Tomography And NEphropathy: The OCTANE Study
Enrollment
150 pts
Location
United Kingdom
Sponsor
University of Edinburgh
View Trial →
NCT03547856
Recruiting
A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Enrollment
10,000 pts
Location
China
Sponsor
Yan Li
View Trial →
NCT06049420
Recruiting
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
Enrollment
95 pts
Location
United States
Sponsor
West Virginia School of Osteop...
View Trial →
NCT07614724
Recruiting
Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)
Enrollment
72 pts
Location
China
Sponsor
Peking University
View Trial →
NCT07511361 Phase 2
Recruiting
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Enrollment
140 pts
Location
United States
Sponsor
Kardigan, Inc.
View Trial →
NCT07444138
Recruiting
Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women
Enrollment
20 pts
Location
Brazil
Sponsor
São Paulo State University
View Trial →
NCT06871293
Recruiting
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Enrollment
374 pts
Location
Colombia
Sponsor
Fundación Cardioinfantil Insti...
View Trial →
NCT07465666
Recruiting
A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates
Enrollment
500 pts
Location
United Arab Emirates
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06416761
Recruiting
Genetics in the Progression of Nephropathies
Enrollment
10,000 pts
Location
Italy
Sponsor
Ospedale San Raffaele
View Trial →
NCT06890169
Recruiting
OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities
Enrollment
120 pts
Location
Singapore
Sponsor
Changi General Hospital
View Trial →
NCT05168605
Recruiting
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Enrollment
100 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT06325800
Recruiting
GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry
Enrollment
1,000 pts
Location
Spain
Sponsor
Complejo Hospitalario Universi...
View Trial →
NCT06932029
Recruiting
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
Enrollment
930 pts
Location
United States
Sponsor
Korey Kennelty
View Trial →
NCT06615609
Recruiting
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
Enrollment
536 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT07364175
Recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Enrollment
60 pts
Location
United Kingdom
Sponsor
Cambridge University Hospitals...
View Trial →
NCT04838678 EARLY_Phase 1
Recruiting
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Enrollment
100 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT07890090
Recruiting
THE EFFECT OF EDUCATION IN PATIENTS WITH HYPERTENSION
Enrollment
76 pts
Location
Turkey (Türkiye)
Sponsor
Inonu University
View Trial →
NCT07512609
Recruiting
Environment, Inflammation and Metabolic Diseases Study
Enrollment
8,000 pts
Location
China
Sponsor
Qifu Li
View Trial →
NCT02966665 Phase 1
Recruiting
: Vascular Function in Health and Disease
Enrollment
420 pts
Location
United States
Sponsor
D. Walter Wray
View Trial →
NCT07725250
Recruiting
Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
Enrollment
3,000 pts
Location
United States
Sponsor
National Bureau of Economic Re...
View Trial →
NCT06907524
Recruiting
Preventative Screening and Health Coaching in a Food Insecure Population
Enrollment
200 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT07194733
Recruiting
Supporting VETerans With Kidney Disease Through Food As Medicine
Enrollment
20 pts
Location
United States
Sponsor
VA Eastern Colorado Health Car...
View Trial →
NCT06775028
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
Enrollment
1,250 pts
Location
Bulgaria, Denmark, I...
Sponsor
Heart Care Foundation
View Trial →
NCT03374215
Recruiting
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Enrollment
1,150 pts
Location
United States
Sponsor
National Institute of Diabetes...
View Trial →
NCT06062394
Recruiting
Penn Medicine Healthy Heart
Enrollment
1,980 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT05703386
Recruiting
Imaging the Pathogenesis of Cerebral Small Vessel Disease
Enrollment
50 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT06557005
Recruiting
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
Enrollment
1,320 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07447362
Recruiting
Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study
Enrollment
220 pts
Location
Chile
Sponsor
Universidad Católica San Anton...
View Trial →
NCT03042988
Recruiting
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Enrollment
20 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT06868069
Recruiting
Study on Blood Pressure Variability and Frailty in the Older People
Enrollment
220 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →
NCT07693699
Recruiting
Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care
Enrollment
150 pts
Location
United States
Sponsor
Wake Forest University Health ...
View Trial →
NCT06281665 Phase 4
Recruiting
Treatment With Aspirin After Preeclampsia: TAP Trial
Enrollment
60 pts
Location
United States
Sponsor
Malamo Countouris
View Trial →
NCT06693934
Recruiting
Jockey Club Precision Prevention Programme on Young Onset Diabetes
Enrollment
9,000 pts
Location
Hong Kong
Sponsor
Juliana CN Chan
View Trial →
NCT06132477 Phase 4
Recruiting
Impact GLP-1 Agonists Following Bariatric
Enrollment
150 pts
Location
United States
Sponsor
University of Missouri-Columbi...
View Trial →
NCT06868719
Recruiting
Ketone Ester And Salt (KEAS) in Older Adults
Enrollment
35 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06670677
Recruiting
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
Enrollment
15,000 pts
Location
Switzerland, United ...
Sponsor
Aktiia SA
View Trial →
NCT06105775
Recruiting
Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies
Enrollment
144 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT06777927
Recruiting
Exergaming Training Among Hypertensive Patients
Enrollment
81 pts
Location
Pakistan
Sponsor
Riphah International Universit...
View Trial →
NCT03549754
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Enrollment
35,000 pts
Location
Brazil, Chile, Costa...
Sponsor
AstraZeneca
View Trial →
NCT07827560
Recruiting
Acupressure to Improve Insomnia Among the Elderly With Hypertension
Enrollment
94 pts
Location
Vietnam
Sponsor
Phenikaa University
View Trial →
NCT06730230
Recruiting
Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
Enrollment
300 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT07758634 Phase 1, Phase 2
Recruiting
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Enrollment
69 pts
Location
United States, Austr...
Sponsor
CRISPR Therapeutics AG
View Trial →

Related Conditions

diabetes mellitus (7) diabetes (6) obesity (6) cardiovascular diseases (4) heart failure (4) dyslipidemia (3) blood pressure (3) hyperlipidemias (3) left ventricular hypertrophy (2) anxiety (2) kidney diseases (2) vascular diseases (2)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology